The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab

Teresa Magnes, Thomas Melchardt, Clemens Hufnagl, Christof Mittermair, Daniel Neureiter, E. Klieser, Gabriel Rinnerthaler, Sebastian Roesch, Alexander Gaggl, Richard Greil,

The Pharmacogenomics Journal · 2017 · 23 citations · 27 references

DOIFull text

Open access

Concepts

References

27